Genetic Testing Services Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Predictive Testing, Carrier Testing, Prenatal Testing, Newborn Screening, Diagnostic Genetic Testing, and Others), Disease (Cancer, Cardiovascular Diseases, Metabolic Diseases, and Other Diseases), Service Provider (Hospital-Based Laboratories, Diagnostic Laboratories, and Others), and Geography
The genetic testing services market size is projected to reach US$ 12.48 billion by 2031 from US$ 3.86 billion in 2023. The market is expected to register a CAGR of 15.8% during 2023–2031.
The growth of the genetic testing services market is attributed to the growing prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and growing preference for direct-to-consumer genetic testing. However, the social and ethical implications of genetic testing and the affordability of genetic services hinder market growth.
Emerging countries such as China, India, Mexico, and Brazil offer significant growth opportunities to market players. The high growth can majorly be attributed to the increasing public healthcare expenditure, improving healthcare infrastructure, and the presence of a large target patient population. The need for genetic testing has also increased owing to a rise in awareness of genetic disorders and their early diagnosis in developing economies.
The quality and availability of genetic services may differ between high-income countries and low- to middle-income countries. For instance, in the US, Australia, Canada, the UK, and other European countries, genetic services are well-advanced, established, and extensive. These services include newborn screening, carrier identification screening, and prenatal diagnosis. Yet, in many high-income countries, genetic services that are offered in multiple settings still need improved systems of assessment.
The ease and applicability of genetic testing procedures have benefitted R&D activities in Asia Pacific and other developing regions worldwide. Major market players are focusing on strategies and initiatives, such as agreements, collaborations, partnerships, and expansions, to improve their product availability, accessibility, and distribution networks in these countries, as it will help them address the growing need for early diagnosis and treatment. For instance, in 2019, GENOMIKA, one of the leading genetic testing laboratories in Brazil, reached an agreement with Veritas to incorporate Whole Genome Sequencing and all the services associated with these tests in the field of preventive medicine and clinical genetics into its portfolio.
The Chinese government identifies genomics as an important strategic field in its 14th Five-Year Plan (2016–2020) for the country's economic and social development. In 2016, the Chinese Academy of Sciences launched the Precision Medicine Initiative, a 14-year project worth US$ 9.2 billion to sequence more than 100 million human genomes by 2030. In December 2017, China's Ministry of Science and Technology collaborated with a human genome research project to document the genetic makeup of 100,000 people. Using the genetic data of nine different minority groups, researchers desire to decode hereditary information within genes. In addition, rising consumer awareness regarding DTC genetic tests in developing economies offers growth opportunities to the DTC industry.
Therefore, emerging markets in developing countries are anticipated to offer significant growth opportunities to the players operating in the market and boost the market growth during the forecast period.
As of 2018, there were ~75,000 genetic tests available in the market, with nearly ten new tests entering the market every day. As per the study "Trends in Availability of Genetic Tests in the United States, 2012–2022," published in 2023, ~129,624 and 197,779 genetic tests in the US and globally, respectively, have been made accessible and submitted to the genetic testing registry as of November 2022. These tests have been extended from single-gene tests to panels that look at multiple genes. To solve the growing problem of health data exhaust, the field of medicine is increasingly revolving around enhanced clinical tools, such as artificial intelligence (AI) and machine learning, which have been mentioned as a way to improve the acceptance of genomic medicine. Today, many companies have turned to machine learning to process the vast amount of data needed to correctly analyze and understand clinical data in fields such as radiology and cardiology.
Many of the consumer-facing genetic testing technologies that are available in the market are using machine learning or AI to function. In numerous ways, genetic testing of diseases is the perfect field for machine learning because of the vast volumes of data that these programs need to struggle with. For example, working on the human genome includes reading billions of bits of information, and prior to the introduction of machine learning, many of these tasks were pretty tricky. AI offers great potential when it comes to analyzing genetic data and supporting clinical specialists in making diagnoses.
Google has a program called Deep Variant that can now be used to plot the human genome thoroughly and can be used on the full range of a person's genetic information. Moreover, agencies such as the National Institutes of Health are working on ways through which machine learning and AI can add to a better understanding of genetics and genomics. Thus, through the successful integration of these tools, clinicians will be able to diagnose rare genetic diseases more efficiently and effectively.
Service Provider -Based Insights
Based on service provider, the genetic testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and others. In 2023, the hospital-based laboratories segment held the largest share of the market and is anticipated to register the highest CAGR during 2023–2031. Hospital-based laboratories are genetic testing service providers that operate within a hospital setting. Hospital laboratories can be segmented by type of testing and staffed by personnel trained in particular specialties. For instance, some sections can focus on microbiology, hematology, chemistry, and blood banking. At the same time, some units may perform highly specialized genetic tests using electron microscopy and immunohistochemistry, and others can focus on surgical pathology and cytology, which are all linked with the investigation of cell and tissue structure. The market growth for the segment can be due to the compulsory newborn screening for genetic disorders and the growing prevalence of cancer in many regions.
Seattle Children's Hospital in Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI) region provides comprehensive genetic testing and consultative services to healthcare workers and families. Their genetics laboratories consist of molecular genetics, cytogenetics, biochemical genetics, and a research and development laboratory devoted to bringing the most existing and specific research tests into the clinical field. Overall, these laboratories play a crucial role in helping to diagnose genetic disorders, guide treatment decisions, and improve patient outcomes.
Centers for Disease Control and Prevention, the US Food and Drug Administration, the World Health Organization, and are among the primary and secondary sources referred to while preparing the genetic testing services market report.
The growth of the genetic testing services market is attributed to the growing prevalence of genetic diseases, increasing awareness and acceptance of personalized medicines, and growing preference for direct-to-consumer genetic testing. However, the social and ethical implications of genetic testing and the affordability of genetic services hinder market growth.
Emerging countries such as China, India, Mexico, and Brazil offer significant growth opportunities to market players. The high growth can majorly be attributed to the increasing public healthcare expenditure, improving healthcare infrastructure, and the presence of a large target patient population. The need for genetic testing has also increased owing to a rise in awareness of genetic disorders and their early diagnosis in developing economies.
The quality and availability of genetic services may differ between high-income countries and low- to middle-income countries. For instance, in the US, Australia, Canada, the UK, and other European countries, genetic services are well-advanced, established, and extensive. These services include newborn screening, carrier identification screening, and prenatal diagnosis. Yet, in many high-income countries, genetic services that are offered in multiple settings still need improved systems of assessment.
The ease and applicability of genetic testing procedures have benefitted R&D activities in Asia Pacific and other developing regions worldwide. Major market players are focusing on strategies and initiatives, such as agreements, collaborations, partnerships, and expansions, to improve their product availability, accessibility, and distribution networks in these countries, as it will help them address the growing need for early diagnosis and treatment. For instance, in 2019, GENOMIKA, one of the leading genetic testing laboratories in Brazil, reached an agreement with Veritas to incorporate Whole Genome Sequencing and all the services associated with these tests in the field of preventive medicine and clinical genetics into its portfolio.
The Chinese government identifies genomics as an important strategic field in its 14th Five-Year Plan (2016–2020) for the country's economic and social development. In 2016, the Chinese Academy of Sciences launched the Precision Medicine Initiative, a 14-year project worth US$ 9.2 billion to sequence more than 100 million human genomes by 2030. In December 2017, China's Ministry of Science and Technology collaborated with a human genome research project to document the genetic makeup of 100,000 people. Using the genetic data of nine different minority groups, researchers desire to decode hereditary information within genes. In addition, rising consumer awareness regarding DTC genetic tests in developing economies offers growth opportunities to the DTC industry.
Therefore, emerging markets in developing countries are anticipated to offer significant growth opportunities to the players operating in the market and boost the market growth during the forecast period.
As of 2018, there were ~75,000 genetic tests available in the market, with nearly ten new tests entering the market every day. As per the study "Trends in Availability of Genetic Tests in the United States, 2012–2022," published in 2023, ~129,624 and 197,779 genetic tests in the US and globally, respectively, have been made accessible and submitted to the genetic testing registry as of November 2022. These tests have been extended from single-gene tests to panels that look at multiple genes. To solve the growing problem of health data exhaust, the field of medicine is increasingly revolving around enhanced clinical tools, such as artificial intelligence (AI) and machine learning, which have been mentioned as a way to improve the acceptance of genomic medicine. Today, many companies have turned to machine learning to process the vast amount of data needed to correctly analyze and understand clinical data in fields such as radiology and cardiology.
Many of the consumer-facing genetic testing technologies that are available in the market are using machine learning or AI to function. In numerous ways, genetic testing of diseases is the perfect field for machine learning because of the vast volumes of data that these programs need to struggle with. For example, working on the human genome includes reading billions of bits of information, and prior to the introduction of machine learning, many of these tasks were pretty tricky. AI offers great potential when it comes to analyzing genetic data and supporting clinical specialists in making diagnoses.
Google has a program called Deep Variant that can now be used to plot the human genome thoroughly and can be used on the full range of a person's genetic information. Moreover, agencies such as the National Institutes of Health are working on ways through which machine learning and AI can add to a better understanding of genetics and genomics. Thus, through the successful integration of these tools, clinicians will be able to diagnose rare genetic diseases more efficiently and effectively.
Service Provider -Based Insights
Based on service provider, the genetic testing services market is segmented into hospital-based laboratories, diagnostic laboratories, and others. In 2023, the hospital-based laboratories segment held the largest share of the market and is anticipated to register the highest CAGR during 2023–2031. Hospital-based laboratories are genetic testing service providers that operate within a hospital setting. Hospital laboratories can be segmented by type of testing and staffed by personnel trained in particular specialties. For instance, some sections can focus on microbiology, hematology, chemistry, and blood banking. At the same time, some units may perform highly specialized genetic tests using electron microscopy and immunohistochemistry, and others can focus on surgical pathology and cytology, which are all linked with the investigation of cell and tissue structure. The market growth for the segment can be due to the compulsory newborn screening for genetic disorders and the growing prevalence of cancer in many regions.
Seattle Children's Hospital in Washington, Wyoming, Alaska, Montana, and Idaho (WWAMI) region provides comprehensive genetic testing and consultative services to healthcare workers and families. Their genetics laboratories consist of molecular genetics, cytogenetics, biochemical genetics, and a research and development laboratory devoted to bringing the most existing and specific research tests into the clinical field. Overall, these laboratories play a crucial role in helping to diagnose genetic disorders, guide treatment decisions, and improve patient outcomes.
Centers for Disease Control and Prevention, the US Food and Drug Administration, the World Health Organization, and are among the primary and secondary sources referred to while preparing the genetic testing services market report.
1. INTRODUCTION
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Data Triangulation:
3.2.4 Country level data:
4. GENETIC TESTING SERVICES MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. GENETIC TESTING SERVICES MARKET – KEY MARKET DYNAMICS
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Genetic Diseases
5.1.2 Increasing Awareness and Acceptance of Personalized Medicines
5.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
5.2 Market Restraints
5.2.1 Social and Ethical Implications of Genetic Testing
5.2.2 Affordability of Genetic Services
5.3 Market Opportunities
5.3.1 Untapped Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Artificial Intelligence-Powered Genetic Testing
5.5 Impact Analysis:
6. GENETIC TESTING SERVICES MARKET – GLOBAL MARKET ANALYSIS
6.1 Genetic Testing Services Market Revenue (US$ Million), 2021–2031
6.2 Genetic Testing Services Market Forecast Analysis
7. GENETIC TESTING SERVICES MARKET ANALYSIS – BY SERVICE TYPE
7.1 Predictive Testing
7.1.1 Overview
7.1.2 Predictive Testing: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Carrier Testing
7.2.1 Overview
7.2.2 Carrier Testing: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Prenatal Testing
7.3.1 Overview
7.3.2 Prenatal Testing: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Newborn Screening
7.4.1 Overview
7.4.2 Newborn Screening: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Diagnostic Genetic Testing
7.5.1 Overview
7.5.2 Diagnostic Genetic Testing: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
8. GENETIC TESTING SERVICES MARKET ANALYSIS – BY DISEASE
8.1 Cancer
8.1.1 Overview
8.1.2 Cancer: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Cardiovascular Diseases
8.2.1 Overview
8.2.2 Cardiovascular Diseases: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Metabolic Diseases
8.3.1 Overview
8.3.2 Metabolic Diseases: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Other Diseases
8.4.1 Overview
8.4.2 Other Diseases: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
9. GENETIC TESTING SERVICES MARKET ANALYSIS – BY SERVICE PROVIDER
9.1 Hospital-Based Laboratories
9.1.1 Overview
9.1.2 Hospital-Based Laboratories: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Diagnostic Laboratories
9.2.1 Overview
9.2.2 Diagnostic Laboratories: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10. GENETIC TESTING SERVICES MARKET – GEOGRAPHICAL ANALYSIS
10.1 Overview
10.2 North America
10.2.1 North America Genetic Testing Services Market Overview
10.2.2 North America: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.2.1 North America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Type
10.2.2.2 North America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease
10.2.2.3 North America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider
10.2.3 North America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
10.2.3.1 US
10.2.3.1.1 Overview
10.2.3.2 United States: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.2.1 United States: Genetic Testing Services Market Breakdown, by Service Type
10.2.3.2.2 United States: Genetic Testing Services Market Breakdown, by Disease
10.2.3.2.3 United States: Genetic Testing Services Market Breakdown, by Service Provider
10.2.3.3 Canada
10.2.3.3.1 Overview
10.2.3.4 Canada: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.4.1 Canada: Genetic Testing Services Market Breakdown, by Service Type
10.2.3.4.2 Canada: Genetic Testing Services Market Breakdown, by Disease
10.2.3.4.3 Canada: Genetic Testing Services Market Breakdown, by Service Provider
10.2.3.5 Mexico
10.2.3.5.1 Overview
10.2.3.6 Mexico: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.6.1 Mexico: Genetic Testing Services Market Breakdown, by Service Type
10.2.3.6.2 Mexico: Genetic Testing Services Market Breakdown, by Disease
10.2.3.6.3 Mexico: Genetic Testing Services Market Breakdown, by Service Provider
10.3 Europe
10.3.1 Europe Genetic Testing Services Market Overview
10.3.2 Europe: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.2.1 Europe: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Type
10.3.2.2 Europe: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease
10.3.2.3 Europe: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider
10.3.3 Europe: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
10.3.3.1 UK
10.3.3.1.1 Overview
10.3.3.2 United Kingdom: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.2.1 United Kingdom: Genetic Testing Services Market Breakdown, by Service Type
10.3.3.2.2 United Kingdom: Genetic Testing Services Market Breakdown, by Disease
10.3.3.2.3 United Kingdom: Genetic Testing Services Market Breakdown, by Service Provider
10.3.3.3 Germany
10.3.3.3.1 Overview
10.3.3.4 Germany: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.4.1 Germany: Genetic Testing Services Market Breakdown, by Service Type
10.3.3.4.2 Germany: Genetic Testing Services Market Breakdown, by Disease
10.3.3.4.3 Germany: Genetic Testing Services Market Breakdown, by Service Provider
10.3.3.5 France
10.3.3.5.1 Overview
10.3.3.6 France: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.6.1 France: Genetic Testing Services Market Breakdown, by Service Type
10.3.3.6.2 France: Genetic Testing Services Market Breakdown, by Disease
10.3.3.6.3 France: Genetic Testing Services Market Breakdown, by Service Provider
10.3.3.7 Spain
10.3.3.7.1 Overview
10.3.3.8 Spain: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.8.1 Spain: Genetic Testing Services Market Breakdown, by Service Type
10.3.3.8.2 Spain: Genetic Testing Services Market Breakdown, by Disease
10.3.3.8.3 Spain: Genetic Testing Services Market Breakdown, by Service Provider
10.3.3.9 Italy
10.3.3.9.1 Overview
10.3.3.10 Italy: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.10.1 Italy: Genetic Testing Services Market Breakdown, by Service Type
10.3.3.10.2 Italy: Genetic Testing Services Market Breakdown, by Disease
10.3.3.10.3 Italy: Genetic Testing Services Market Breakdown, by Service Provider
10.3.3.11 Rest of Europe
10.3.3.11.1 Overview
10.3.3.12 Rest of Europe: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.12.1 Rest of Europe: Genetic Testing Services Market Breakdown, by Service Type
10.3.3.12.2 Rest of Europe: Genetic Testing Services Market Breakdown, by Disease
10.3.3.12.3 Rest of Europe: Genetic Testing Services Market Breakdown, by Service Provider
10.4 Asia Pacific
10.4.1 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.1.1 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Type
10.4.1.2 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease
10.4.1.3 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider
10.4.2 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
10.4.2.1 China
10.4.2.1.1 Overview
10.4.2.2 China: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.2.2.1 China: Genetic Testing Services Market Breakdown, by Service Type
10.4.2.2.2 China: Genetic Testing Services Market Breakdown, by Disease
10.4.2.2.3 China: Genetic Testing Services Market Breakdown, by Service Provider
10.4.2.3 Japan
10.4.2.3.1 Overview
10.4.2.4 Japan: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.2.4.1 Japan: Genetic Testing Services Market Breakdown, by Service Type
10.4.2.4.2 Japan: Genetic Testing Services Market Breakdown, by Disease
10.4.2.4.3 Japan: Genetic Testing Services Market Breakdown, by Service Provider
10.4.2.5 India
10.4.2.5.1 Overview
10.4.2.6 India: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.2.6.1 India: Genetic Testing Services Market Breakdown, by Service Type
10.4.2.6.2 India: Genetic Testing Services Market Breakdown, by Disease
10.4.2.6.3 India: Genetic Testing Services Market Breakdown, by Service Provider
10.4.2.7 Australia
10.4.2.7.1 Overview
10.4.2.8 Australia: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.2.8.1 Australia: Genetic Testing Services Market Breakdown, by Service Type
10.4.2.8.2 Australia: Genetic Testing Services Market Breakdown, by Disease
10.4.2.8.3 Australia: Genetic Testing Services Market Breakdown, by Service Provider
10.4.2.9 South Korea
10.4.2.9.1 Overview
10.4.2.10 South Korea: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.2.10.1 South Korea: Genetic Testing Services Market Breakdown, by Service Type
10.4.2.10.2 South Korea: Genetic Testing Services Market Breakdown, by Disease
10.4.2.10.3 South Korea: Genetic Testing Services Market Breakdown, by Service Provider
10.4.2.11 Rest of Asia Pacific
10.4.2.11.1 Overview
10.4.2.12 Rest of APAC: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.2.12.1 Rest of APAC: Genetic Testing Services Market Breakdown, by Service Type
10.4.2.12.2 Rest of APAC: Genetic Testing Services Market Breakdown, by Disease
10.4.2.12.3 Rest of APAC: Genetic Testing Services Market Breakdown, by Service Provider
10.5 Middle East and Africa
10.5.1 Middle East and Africa Genetic Testing Services Market Overview
10.5.2 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.2.1 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Type
10.5.2.2 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease
10.5.2.3 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider
10.5.3 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
10.5.3.1 Saudi Arabia
10.5.3.1.1 Overview
10.5.3.2 Saudi Arabia: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.2.1 Saudi Arabia: Genetic Testing Services Market Breakdown, by Service Type
10.5.3.2.2 Saudi Arabia: Genetic Testing Services Market Breakdown, by Disease
10.5.3.2.3 Saudi Arabia: Genetic Testing Services Market Breakdown, by Service Provider
10.5.3.3 South Africa
10.5.3.3.1 Overview
10.5.3.4 South Africa: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.4.1 South Africa: Genetic Testing Services Market Breakdown, by Service Type
10.5.3.4.2 South Africa: Genetic Testing Services Market Breakdown, by Disease
10.5.3.4.3 South Africa: Genetic Testing Services Market Breakdown, by Service Provider
10.5.3.5 UAE
10.5.3.5.1 Overview
10.5.3.6 United Arab Emirates: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.6.1 United Arab Emirates: Genetic Testing Services Market Breakdown, by Service Type
10.5.3.6.2 United Arab Emirates: Genetic Testing Services Market Breakdown, by Disease
10.5.3.6.3 United Arab Emirates: Genetic Testing Services Market Breakdown, by Service Provider
10.5.3.7 Rest of Middle East & Africa
10.5.3.7.1 Overview
10.5.3.8 Rest of Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.8.1 Rest of Middle East and Africa: Genetic Testing Services Market Breakdown, by Service Type
10.5.3.8.2 Rest of Middle East and Africa: Genetic Testing Services Market Breakdown, by Disease
10.5.3.8.3 Rest of Middle East and Africa: Genetic Testing Services Market Breakdown, by Service Provider
10.6 South and Central America
10.6.1 South and Central America Genetic Testing Services Market Overview
10.6.2 South and Central America: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.2.1 South and Central America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Type
10.6.2.2 South and Central America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease
10.6.2.3 South and Central America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider
10.6.3 South and Central America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
10.6.3.1 Brazil
10.6.3.1.1 Overview
10.6.3.2 Brazil: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3.2.1 Brazil: Genetic Testing Services Market Breakdown, by Service Type
10.6.3.2.2 Brazil: Genetic Testing Services Market Breakdown, by Disease
10.6.3.2.3 Brazil: Genetic Testing Services Market Breakdown, by Service Provider
10.6.3.3 Argentina
10.6.3.3.1 Overview
10.6.3.4 Argentina: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3.4.1 Argentina: Genetic Testing Services Market Breakdown, by Service Type
10.6.3.4.2 Argentina: Genetic Testing Services Market Breakdown, by Disease
10.6.3.4.3 Argentina: Genetic Testing Services Market Breakdown, by Service Provider
10.6.3.3 Chile
10.6.3.3.1 Overview
10.6.3.4 Chile: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3.4.1 Chile: Genetic Testing Services Market Breakdown, by Service Type
10.6.3.4.2 Chile: Genetic Testing Services Market Breakdown, by Disease
10.6.3.4.3 Chile: Genetic Testing Services Market Breakdown, by Service Provider
10.6.3.3 Colombia
10.6.3.3.1 Overview
10.6.3.4 Colombia: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3.4.1 Colombia: Genetic Testing Services Market Breakdown, by Service Type
10.6.3.4.2 Colombia: Genetic Testing Services Market Breakdown, by Disease
10.6.3.4.3 Colombia: Genetic Testing Services Market Breakdown, by Service Provider
10.6.3.5 Rest of South & Central America
10.6.3.5.1 Overview
10.6.3.6 Rest of South and Central America: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3.6.1 Rest of South and Central America: Genetic Testing Services Market Breakdown, by Service Type
10.6.3.6.2 Rest of South and Central America: Genetic Testing Services Market Breakdown, by Disease
10.6.3.6.3 Rest of South and Central America: Genetic Testing Services Market Breakdown, by Service Provider
11. GENETIC TESTING SERVICES MARKET – INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in Genetic Testing Services Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Eurofins Scientific SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Exact Sciences Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Laboratory Corp of America Holdings
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4andMe Holding Co
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Ambry Genetics Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Quest Diagnostics Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Illumina Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NeoGenomics Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Centogene NV
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Ancestry Genomics Inc
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Gene By Gene Ltd
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 SIVOTEC BioInformatics LLC
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
12.14 Progenesis
12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 Financial Overview
12.14.5 SWOT Analysis
12.14.6 Key Developments
12.15 Fulgent Genetics, Inc
12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 Financial Overview
12.15.5 SWOT Analysis
12.15.6 Key Developments
12.16 VERITAS INTERCONTINENTAL
12.16.1 Business Description
12.16.2 Products and Services
12.16.3 Financial Overview
12.16.4 SWOT Analysis
12.16.5 Key Developments
12.17 GeneDx, LLC
12.17.1 Key Facts
12.17.2 Business Description
12.17.3 Products and Services
12.17.4 Financial Overview
12.17.5 SWOT Analysis
12.17.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Data Triangulation:
3.2.4 Country level data:
4. GENETIC TESTING SERVICES MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
5. GENETIC TESTING SERVICES MARKET – KEY MARKET DYNAMICS
5.1 Key Market Drivers
5.1.1 Rising Prevalence of Genetic Diseases
5.1.2 Increasing Awareness and Acceptance of Personalized Medicines
5.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
5.2 Market Restraints
5.2.1 Social and Ethical Implications of Genetic Testing
5.2.2 Affordability of Genetic Services
5.3 Market Opportunities
5.3.1 Untapped Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Artificial Intelligence-Powered Genetic Testing
5.5 Impact Analysis:
6. GENETIC TESTING SERVICES MARKET – GLOBAL MARKET ANALYSIS
6.1 Genetic Testing Services Market Revenue (US$ Million), 2021–2031
6.2 Genetic Testing Services Market Forecast Analysis
7. GENETIC TESTING SERVICES MARKET ANALYSIS – BY SERVICE TYPE
7.1 Predictive Testing
7.1.1 Overview
7.1.2 Predictive Testing: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Carrier Testing
7.2.1 Overview
7.2.2 Carrier Testing: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Prenatal Testing
7.3.1 Overview
7.3.2 Prenatal Testing: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Newborn Screening
7.4.1 Overview
7.4.2 Newborn Screening: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Diagnostic Genetic Testing
7.5.1 Overview
7.5.2 Diagnostic Genetic Testing: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
8. GENETIC TESTING SERVICES MARKET ANALYSIS – BY DISEASE
8.1 Cancer
8.1.1 Overview
8.1.2 Cancer: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Cardiovascular Diseases
8.2.1 Overview
8.2.2 Cardiovascular Diseases: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Metabolic Diseases
8.3.1 Overview
8.3.2 Metabolic Diseases: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Other Diseases
8.4.1 Overview
8.4.2 Other Diseases: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
9. GENETIC TESTING SERVICES MARKET ANALYSIS – BY SERVICE PROVIDER
9.1 Hospital-Based Laboratories
9.1.1 Overview
9.1.2 Hospital-Based Laboratories: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Diagnostic Laboratories
9.2.1 Overview
9.2.2 Diagnostic Laboratories: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10. GENETIC TESTING SERVICES MARKET – GEOGRAPHICAL ANALYSIS
10.1 Overview
10.2 North America
10.2.1 North America Genetic Testing Services Market Overview
10.2.2 North America: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.2.1 North America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Type
10.2.2.2 North America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease
10.2.2.3 North America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider
10.2.3 North America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
10.2.3.1 US
10.2.3.1.1 Overview
10.2.3.2 United States: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.2.1 United States: Genetic Testing Services Market Breakdown, by Service Type
10.2.3.2.2 United States: Genetic Testing Services Market Breakdown, by Disease
10.2.3.2.3 United States: Genetic Testing Services Market Breakdown, by Service Provider
10.2.3.3 Canada
10.2.3.3.1 Overview
10.2.3.4 Canada: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.4.1 Canada: Genetic Testing Services Market Breakdown, by Service Type
10.2.3.4.2 Canada: Genetic Testing Services Market Breakdown, by Disease
10.2.3.4.3 Canada: Genetic Testing Services Market Breakdown, by Service Provider
10.2.3.5 Mexico
10.2.3.5.1 Overview
10.2.3.6 Mexico: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.2.3.6.1 Mexico: Genetic Testing Services Market Breakdown, by Service Type
10.2.3.6.2 Mexico: Genetic Testing Services Market Breakdown, by Disease
10.2.3.6.3 Mexico: Genetic Testing Services Market Breakdown, by Service Provider
10.3 Europe
10.3.1 Europe Genetic Testing Services Market Overview
10.3.2 Europe: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.2.1 Europe: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Type
10.3.2.2 Europe: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease
10.3.2.3 Europe: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider
10.3.3 Europe: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
10.3.3.1 UK
10.3.3.1.1 Overview
10.3.3.2 United Kingdom: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.2.1 United Kingdom: Genetic Testing Services Market Breakdown, by Service Type
10.3.3.2.2 United Kingdom: Genetic Testing Services Market Breakdown, by Disease
10.3.3.2.3 United Kingdom: Genetic Testing Services Market Breakdown, by Service Provider
10.3.3.3 Germany
10.3.3.3.1 Overview
10.3.3.4 Germany: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.4.1 Germany: Genetic Testing Services Market Breakdown, by Service Type
10.3.3.4.2 Germany: Genetic Testing Services Market Breakdown, by Disease
10.3.3.4.3 Germany: Genetic Testing Services Market Breakdown, by Service Provider
10.3.3.5 France
10.3.3.5.1 Overview
10.3.3.6 France: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.6.1 France: Genetic Testing Services Market Breakdown, by Service Type
10.3.3.6.2 France: Genetic Testing Services Market Breakdown, by Disease
10.3.3.6.3 France: Genetic Testing Services Market Breakdown, by Service Provider
10.3.3.7 Spain
10.3.3.7.1 Overview
10.3.3.8 Spain: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.8.1 Spain: Genetic Testing Services Market Breakdown, by Service Type
10.3.3.8.2 Spain: Genetic Testing Services Market Breakdown, by Disease
10.3.3.8.3 Spain: Genetic Testing Services Market Breakdown, by Service Provider
10.3.3.9 Italy
10.3.3.9.1 Overview
10.3.3.10 Italy: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.10.1 Italy: Genetic Testing Services Market Breakdown, by Service Type
10.3.3.10.2 Italy: Genetic Testing Services Market Breakdown, by Disease
10.3.3.10.3 Italy: Genetic Testing Services Market Breakdown, by Service Provider
10.3.3.11 Rest of Europe
10.3.3.11.1 Overview
10.3.3.12 Rest of Europe: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.3.3.12.1 Rest of Europe: Genetic Testing Services Market Breakdown, by Service Type
10.3.3.12.2 Rest of Europe: Genetic Testing Services Market Breakdown, by Disease
10.3.3.12.3 Rest of Europe: Genetic Testing Services Market Breakdown, by Service Provider
10.4 Asia Pacific
10.4.1 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.1.1 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Type
10.4.1.2 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease
10.4.1.3 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider
10.4.2 Asia Pacific: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
10.4.2.1 China
10.4.2.1.1 Overview
10.4.2.2 China: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.2.2.1 China: Genetic Testing Services Market Breakdown, by Service Type
10.4.2.2.2 China: Genetic Testing Services Market Breakdown, by Disease
10.4.2.2.3 China: Genetic Testing Services Market Breakdown, by Service Provider
10.4.2.3 Japan
10.4.2.3.1 Overview
10.4.2.4 Japan: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.2.4.1 Japan: Genetic Testing Services Market Breakdown, by Service Type
10.4.2.4.2 Japan: Genetic Testing Services Market Breakdown, by Disease
10.4.2.4.3 Japan: Genetic Testing Services Market Breakdown, by Service Provider
10.4.2.5 India
10.4.2.5.1 Overview
10.4.2.6 India: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.2.6.1 India: Genetic Testing Services Market Breakdown, by Service Type
10.4.2.6.2 India: Genetic Testing Services Market Breakdown, by Disease
10.4.2.6.3 India: Genetic Testing Services Market Breakdown, by Service Provider
10.4.2.7 Australia
10.4.2.7.1 Overview
10.4.2.8 Australia: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.2.8.1 Australia: Genetic Testing Services Market Breakdown, by Service Type
10.4.2.8.2 Australia: Genetic Testing Services Market Breakdown, by Disease
10.4.2.8.3 Australia: Genetic Testing Services Market Breakdown, by Service Provider
10.4.2.9 South Korea
10.4.2.9.1 Overview
10.4.2.10 South Korea: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.2.10.1 South Korea: Genetic Testing Services Market Breakdown, by Service Type
10.4.2.10.2 South Korea: Genetic Testing Services Market Breakdown, by Disease
10.4.2.10.3 South Korea: Genetic Testing Services Market Breakdown, by Service Provider
10.4.2.11 Rest of Asia Pacific
10.4.2.11.1 Overview
10.4.2.12 Rest of APAC: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.4.2.12.1 Rest of APAC: Genetic Testing Services Market Breakdown, by Service Type
10.4.2.12.2 Rest of APAC: Genetic Testing Services Market Breakdown, by Disease
10.4.2.12.3 Rest of APAC: Genetic Testing Services Market Breakdown, by Service Provider
10.5 Middle East and Africa
10.5.1 Middle East and Africa Genetic Testing Services Market Overview
10.5.2 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.2.1 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Type
10.5.2.2 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease
10.5.2.3 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider
10.5.3 Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
10.5.3.1 Saudi Arabia
10.5.3.1.1 Overview
10.5.3.2 Saudi Arabia: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.2.1 Saudi Arabia: Genetic Testing Services Market Breakdown, by Service Type
10.5.3.2.2 Saudi Arabia: Genetic Testing Services Market Breakdown, by Disease
10.5.3.2.3 Saudi Arabia: Genetic Testing Services Market Breakdown, by Service Provider
10.5.3.3 South Africa
10.5.3.3.1 Overview
10.5.3.4 South Africa: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.4.1 South Africa: Genetic Testing Services Market Breakdown, by Service Type
10.5.3.4.2 South Africa: Genetic Testing Services Market Breakdown, by Disease
10.5.3.4.3 South Africa: Genetic Testing Services Market Breakdown, by Service Provider
10.5.3.5 UAE
10.5.3.5.1 Overview
10.5.3.6 United Arab Emirates: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.6.1 United Arab Emirates: Genetic Testing Services Market Breakdown, by Service Type
10.5.3.6.2 United Arab Emirates: Genetic Testing Services Market Breakdown, by Disease
10.5.3.6.3 United Arab Emirates: Genetic Testing Services Market Breakdown, by Service Provider
10.5.3.7 Rest of Middle East & Africa
10.5.3.7.1 Overview
10.5.3.8 Rest of Middle East and Africa: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.5.3.8.1 Rest of Middle East and Africa: Genetic Testing Services Market Breakdown, by Service Type
10.5.3.8.2 Rest of Middle East and Africa: Genetic Testing Services Market Breakdown, by Disease
10.5.3.8.3 Rest of Middle East and Africa: Genetic Testing Services Market Breakdown, by Service Provider
10.6 South and Central America
10.6.1 South and Central America Genetic Testing Services Market Overview
10.6.2 South and Central America: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.2.1 South and Central America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Type
10.6.2.2 South and Central America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Disease
10.6.2.3 South and Central America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Service Provider
10.6.3 South and Central America: Genetic Testing Services Market – Revenue and Forecast Analysis – by Country
10.6.3.1 Brazil
10.6.3.1.1 Overview
10.6.3.2 Brazil: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3.2.1 Brazil: Genetic Testing Services Market Breakdown, by Service Type
10.6.3.2.2 Brazil: Genetic Testing Services Market Breakdown, by Disease
10.6.3.2.3 Brazil: Genetic Testing Services Market Breakdown, by Service Provider
10.6.3.3 Argentina
10.6.3.3.1 Overview
10.6.3.4 Argentina: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3.4.1 Argentina: Genetic Testing Services Market Breakdown, by Service Type
10.6.3.4.2 Argentina: Genetic Testing Services Market Breakdown, by Disease
10.6.3.4.3 Argentina: Genetic Testing Services Market Breakdown, by Service Provider
10.6.3.3 Chile
10.6.3.3.1 Overview
10.6.3.4 Chile: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3.4.1 Chile: Genetic Testing Services Market Breakdown, by Service Type
10.6.3.4.2 Chile: Genetic Testing Services Market Breakdown, by Disease
10.6.3.4.3 Chile: Genetic Testing Services Market Breakdown, by Service Provider
10.6.3.3 Colombia
10.6.3.3.1 Overview
10.6.3.4 Colombia: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3.4.1 Colombia: Genetic Testing Services Market Breakdown, by Service Type
10.6.3.4.2 Colombia: Genetic Testing Services Market Breakdown, by Disease
10.6.3.4.3 Colombia: Genetic Testing Services Market Breakdown, by Service Provider
10.6.3.5 Rest of South & Central America
10.6.3.5.1 Overview
10.6.3.6 Rest of South and Central America: Genetic Testing Services Market – Revenue and Forecast to 2031 (US$ Million)
10.6.3.6.1 Rest of South and Central America: Genetic Testing Services Market Breakdown, by Service Type
10.6.3.6.2 Rest of South and Central America: Genetic Testing Services Market Breakdown, by Disease
10.6.3.6.3 Rest of South and Central America: Genetic Testing Services Market Breakdown, by Service Provider
11. GENETIC TESTING SERVICES MARKET – INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies in Genetic Testing Services Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. COMPANY PROFILES
12.1 Eurofins Scientific SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Exact Sciences Corp
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Laboratory Corp of America Holdings
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4andMe Holding Co
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Ambry Genetics Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Quest Diagnostics Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Illumina Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 F. Hoffmann-La Roche Ltd
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 NeoGenomics Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Centogene NV
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Ancestry Genomics Inc
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Gene By Gene Ltd
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 SIVOTEC BioInformatics LLC
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
12.14 Progenesis
12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 Financial Overview
12.14.5 SWOT Analysis
12.14.6 Key Developments
12.15 Fulgent Genetics, Inc
12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 Financial Overview
12.15.5 SWOT Analysis
12.15.6 Key Developments
12.16 VERITAS INTERCONTINENTAL
12.16.1 Business Description
12.16.2 Products and Services
12.16.3 Financial Overview
12.16.4 SWOT Analysis
12.16.5 Key Developments
12.17 GeneDx, LLC
12.17.1 Key Facts
12.17.2 Business Description
12.17.3 Products and Services
12.17.4 Financial Overview
12.17.5 SWOT Analysis
12.17.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
